101 related articles for article (PubMed ID: 34607940)
1. Cutting Edge: Lung-Resident T Cells Elicited by SARS-CoV-2 Do Not Mediate Protection against Secondary Infection.
Roberts LM; Jessop F; Wehrly TD; Bosio CM
J Immunol; 2021 Nov; 207(10):2399-2404. PubMed ID: 34607940
[TBL] [Abstract][Full Text] [Related]
2. Strong SARS-CoV-2 N-Specific CD8
Ferrantelli F; Chiozzini C; Manfredi F; Leone P; Spada M; Di Virgilio A; Giovannelli A; Sanchez M; Cara A; Michelini Z; Federico M
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215922
[TBL] [Abstract][Full Text] [Related]
3. Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
Joag V; Wijeyesinghe S; Stolley JM; Quarnstrom CF; Dileepan T; Soerens AG; Sangala JA; O'Flanagan SD; Gavil NV; Hong SW; Bhela S; Gangadhara S; Weyu E; Matchett WE; Thiede J; Krishna V; Cheeran MC; Bold TD; Amara R; Southern P; Hart GT; Schifanella L; Vezys V; Jenkins MK; Langlois RA; Masopust D
J Immunol; 2021 Mar; 206(5):931-935. PubMed ID: 33441437
[TBL] [Abstract][Full Text] [Related]
4. A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4
Zayou L; Prakash S; Dhanushkodi NR; Quadiri A; Ibraim IC; Singer M; Salem A; Shaik AM; Suzer B; Chilukuri A; Tran J; Nguyen PC; Sun M; Hormi-Carver KK; Belmouden A; Vahed H; Gil D; Ulmer JB; BenMohamed L
J Virol; 2023 Dec; 97(12):e0109623. PubMed ID: 38038432
[TBL] [Abstract][Full Text] [Related]
5. CD4
Taborska P; Strizova Z; Stakheev D; Sojka L; Bartunkova J; Smrz D
Front Immunol; 2021; 12():629102. PubMed ID: 34012431
[TBL] [Abstract][Full Text] [Related]
6. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
[TBL] [Abstract][Full Text] [Related]
7. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
8. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
[TBL] [Abstract][Full Text] [Related]
9. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
Front Immunol; 2022; 13():817905. PubMed ID: 35185909
[TBL] [Abstract][Full Text] [Related]
10. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
Front Immunol; 2021; 12():751869. PubMed ID: 35003063
[TBL] [Abstract][Full Text] [Related]
11. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
Front Immunol; 2021; 12():797919. PubMed ID: 34975908
[TBL] [Abstract][Full Text] [Related]
12. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
13. Peripheral and lung resident memory T cell responses against SARS-CoV-2.
Grau-Expósito J; Sánchez-Gaona N; Massana N; Suppi M; Astorga-Gamaza A; Perea D; Rosado J; Falcó A; Kirkegaard C; Torrella A; Planas B; Navarro J; Suanzes P; Álvarez-Sierra D; Ayora A; Sansano I; Esperalba J; Andrés C; Antón A; Ramón Y Cajal S; Almirante B; Pujol-Borrell R; Falcó V; Burgos J; Buzón MJ; Genescà M
Nat Commun; 2021 May; 12(1):3010. PubMed ID: 34021148
[TBL] [Abstract][Full Text] [Related]
14. High Frequencies of Functional Virus-Specific CD4
Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
Front Immunol; 2021; 12():748881. PubMed ID: 34858405
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
16. Human coronavirus OC43-elicited CD4
Dos Santos Alves RP; Timis J; Miller R; Valentine K; Pinto PBA; Gonzalez A; Regla-Nava JA; Maule E; Nguyen MN; Shafee N; Landeras-Bueno S; Olmedillas E; Laffey B; Dobaczewska K; Mikulski Z; McArdle S; Leist SR; Kim K; Baric RS; Ollmann Saphire E; Elong Ngono A; Shresta S
Nat Commun; 2024 Jan; 15(1):787. PubMed ID: 38278784
[TBL] [Abstract][Full Text] [Related]
17. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.
Yang LT; Peng H; Zhu ZL; Li G; Huang ZT; Zhao ZX; Koup RA; Bailer RT; Wu CY
Clin Immunol; 2006 Aug; 120(2):171-8. PubMed ID: 16781892
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.
Tian JH; Patel N; Haupt R; Zhou H; Weston S; Hammond H; Logue J; Portnoff AD; Norton J; Guebre-Xabier M; Zhou B; Jacobson K; Maciejewski S; Khatoon R; Wisniewska M; Moffitt W; Kluepfel-Stahl S; Ekechukwu B; Papin J; Boddapati S; Jason Wong C; Piedra PA; Frieman MB; Massare MJ; Fries L; Bengtsson KL; Stertman L; Ellingsworth L; Glenn G; Smith G
Nat Commun; 2021 Jan; 12(1):372. PubMed ID: 33446655
[TBL] [Abstract][Full Text] [Related]
19. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2021; 12():687449. PubMed ID: 34322120
[TBL] [Abstract][Full Text] [Related]
20. Dominant CD8
Taus E; Hofmann C; Ibarrondo FJ; Hausner MA; Fulcher JA; Krogstad P; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
Front Immunol; 2022; 13():835830. PubMed ID: 35273611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
